Skip to main content

Prototype Prescribing Outlier Dashboard for Elgar House

At OpenPrescribing we are piloting a number of data-driven approaches to identify unusual prescribing and collect feedback on this prescribing to inform development of new tools to support prescribers and organisations to audit and review prescribing. These pilot results are provided for the interest of advanced users, although we don't know how relevant they are in practice. There is substantial variation in prescribing behaviours, across various different areas of medicine. Some variation can be explained by demographic changes, or local policies or guidelines, but much of the remaining variation is less easy to explain.

The DataLab is keen to hear your feedback on the results. You can do this by completing the following survey or emailing us at [email protected]. Please DO NOT INCLUDE IDENTIFIABLE PATIENT information in your feedback. All feedback is helpful, you can send short or detailed feedback.

This report has been developed to automatically identify prescribing patterns at a chemical level which are furthest away from “typical prescribing” and can be classified as an “outlier”. We calculate the number of prescriptions for each chemical in the BNF coding system, the count of all prescriptions within that chemical's BNF subparagraph, for prescriptions dispensed between June 2021 and December 2021. We then calculate the ratio of these counts along with the mean and standard deviation of those ratios across all Practices. From this we can calculate the “z-score”, which is a measure of how many standard deviations a given Practice is from the population mean. We then rank your “z-scores” to find the top 10 results where prescribing is an outlier for prescribing higher than its peers and those where it is an outlier for prescribing lower than its peers.

For each outlier chemical, a kernel density estimation plot of all Practice's chemical:subparagraph ratios is provided, with this Practice's ratio overlaid in red.

It is important to remember that this information was generated automatically and it is therefore likely that some of the behaviour is warranted. This report seeks only to collect information about where this variation may be warranted and where it might not, to inform research on this topic. Our full analytical method code is openly available on GitHub here.

This is a new, experimental feature. We'd love to .

Prescribing where Elgar House is higher than most

BNF Chemical Chemical Items BNF Subparagraph Subparagraph Items Ratio Mean std Z_Score Plots
Mexiletine hydrochloride 5 Drugs for arrhythmias 54 0.09 0.00 0.01 9.18
Phenindione 2 Oral anticoagulants 1,761 0.00 0.00 0.00 8.77
Compound alginates and proprietary indigestion preparations 7 Compound Alginates and proprietary indigestion preparations 179 0.04 0.00 0.00 8.50
Ciprofloxacin 39 Otitis externa 226 0.17 0.02 0.03 5.96
Risperidone 8 Antipsychotic depot injections 8 1.00 0.08 0.21 4.44
Antazoline 11 Other anti-inflammatory preparations 85 0.13 0.01 0.03 4.25
Sodium citrate 1 Drugs used in urological pain 1 1.00 0.08 0.24 3.80
Acrivastine 24 Antihistamines 1,007 0.02 0.00 0.01 3.66
Bambuterol hydrochloride 7 Selective beta(2)-agonists 3,375 0.00 0.00 0.00 3.16
Apomorphine hydrochloride 11 Dopaminergic drugs used in parkinsonism 394 0.03 0.00 0.01 3.07

Prescribing where Elgar House is lower than most

BNF Chemical Chemical Items BNF Subparagraph Subparagraph Items Ratio Mean std Z_Score Plots
Potassium citrate 0 Drugs used in urological pain 1 0.00 0.92 0.25 -3.67
    Alginic acid compound preparations 171 Compound Alginates and proprietary indigestion preparations 179 0.96 1.00 0.01 -3.28
    Aciclovir 84 Herpes simplex and varicella-zoster 104 0.81 0.95 0.07 -2.20
    Tiotropium bromide 149 Antimuscarinic bronchodilators 416 0.36 0.71 0.18 -1.96
    Naftidrofuryl oxalate 0 Peripheral vasodilators and related drugs 7 0.00 0.67 0.39 -1.73
      Light liquid paraffin 0 Emollient bath and shower preparations 32 0.00 0.34 0.20 -1.65
        Estradiol with progestogen 115 Oestrogens and Hormone Replacement Therapy 564 0.20 0.39 0.12 -1.57
        Timolol 9 Treatment of glaucoma 1,097 0.01 0.06 0.03 -1.54
        Ferrous fumarate 103 Oral iron 481 0.21 0.57 0.23 -1.52
        Medroxyprogesterone acetate 0 Progestogens 1 0.00 0.66 0.45 -1.46